A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Vinther Jensen, Tua ^a,b   Larsen, Ida U ^a,b   Hjermind, Lena E ^a,b   Budtz Jørgensen, Esben ^b   Nielsen, Troels T ^a,b   Nørremølle, Anne ^b   Nielsen, Jørgen E ^a,b   Vogel, Asmus ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical classification; Cognitive impairment; Huntington's disease; Neuropsychiatry; Premanifest

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL CLASSIFICATION; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; GENE; GENE FREQUENCY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; OUTPATIENT DEPARTMENT; COGNITION DISORDERS; PSYCHOLOGY; YOUNG ADULT;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; YOUNG ADULT;

EID: 84904445752     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-014-0114-8     Document Type: Article

References (42)

1. Huntington's disease. FO Walker, Semin Neurol 2007 27 143 150 10.1055/s-2007-971176 17390259 (Pubitemid 46564475)
2. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993 72 971 983 10.1016/0092-8674(93)90585-E (Pubitemid 23110238)
3. On Chorea. G Huntington, Med Surg Rep 1872 26 317 321
4. Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. GE Berrios, AC Wagle, IS Markova, SA Wagle, A Rosser, JR Hodges, Acta Psychiatr Scand 2002 105 224 230 10.1034/j.1600-0447.2002.0o456.x 11939977 (Pubitemid 34280696)
5. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. JS Paulsen, DR Langbehn, JC Stout, E Aylward, CA Ross, M Nance, M Guttman, S Johnson, M MacDonald, LJ Beglinger, K Duff, E Kayson, K Biglan, I Shoulson, D Oakes, M Hayden, J Neurol Neurosurg Psychiatry 2008 79 874 880 10.1136/jnnp.2007.128728 18096682
6. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. E van Duijn, EM Kingma, R Timman, FG Zitman, A Tibben, RA Roos, RC van der Mast, J Clin Psychiatry 2008 69 1804 1810 10.4088/JCP.v69n1116 19026253
7. Rate of functional decline in Huntington's disease. Huntington Study Group. K Marder, H Zhao, RH Myers, M Cudkowicz, E Kayson, K Kieburtz, C Orme, J Paulsen, JB Penney Jr, E Siemers, I Shoulson, Neurology 2000 54 452 458 10.1212/WNL.54.2.452 10668713 (Pubitemid 30078083)
8. Is a motor criterion essential for the diagnosis of clinical Huntington disease? CT Loy, EA McCusker, PLoS Curr 2013 23653281
9. Psychopathology in verified Huntington's disease gene carriers. E van Duijn, EM Kingma, RC van der Mast, J Neuropsychiatry Clin Neurosci 2007 19 441 448 10.1176/appi.neuropsych.19.4.441 18070848 (Pubitemid 350156103)
10. Psychiatric disorders in preclinical Huntington's disease. CL Julien, JC Thompson, S Wild, P Yardumian, JS Snowden, G Turner, D Craufurd, J Neurol Neurosurg Psychiatry 2007 78 939 943 10.1136/jnnp.2006.103309 17178819 (Pubitemid 47310828)
11. Longitudinal personality changes among presymptomatic Huntington disease gene carriers. SC Kirkwood, E Siemers, R Viken, ME Hodes, PM Conneally, JC Christian, T Foroud, Neuropsychiatry Neuropsychol Behav Neurol 2002 15 192 197 12218712 (Pubitemid 35006774)
12. Clinical markers of early disease in persons near onset of Huntington's disease. JS Paulsen, H Zhao, JC Stout, RR Brinkman, M Guttman, CA Ross, P Como, C Manning, MR Hayden, I Shoulson, Neurology 2001 57 658 662 10.1212/WNL.57.4.658 11524475 (Pubitemid 32782994)
13. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. SJ Tabrizi, DR Langbehn, BR Leavitt, RA Roos, A Durr, D Craufurd, C Kennard, SL Hicks, NC Fox, RI Scahill, B Borowsky, AJ Tobin, HD Rosas, H Johnson, R Reilmann, B Landwehrmeyer, JC Stout, Lancet Neurol 2009 8 791 801 10.1016/S1474-4422(09)70170-X 19646924
14. Episodic memory impairment in Huntington's disease: a meta-analysis. A Montoya, M Pelletier, M Menear, E Duplessis, F Richer, M Lepage, Neuropsychologia 2006 44 1984 1994 10.1016/j.neuropsychologia.2006.01.015 16797615 (Pubitemid 43927985)
15. Preparing for preventive clinical trials: the Predict-HD study. JS Paulsen, M Hayden, JC Stout, DR Langbehn, E Aylward, CA Ross, M Guttman, M Nance, K Kieburtz, D Oakes, I Shoulson, E Kayson, S Johnson, E Penziner, Arch Neurol 2006 63 883 890 10.1001/archneur.63.6.883 16769871 (Pubitemid 43882298)
16. Neurocognitive signs in prodromal Huntington disease. JC Stout, JS Paulsen, S Queller, AC Solomon, KB Withlock, JC Campbell, NE Carlozzi, K Duff, LJ Beglinger, DR Langbehn, S Johnson, K Biglan, EH Aylward, Neuropsychology 2011 25 1 14 10.1037/a0020937 20919768
17. Mild cognitive impairment in prediagnosed Huntington disease. K Duff, J Paulsen, J Mills, LJ Beglinger, DJ Moser, MM Smith, D Langbehn, J Stout, S Queller, DL Harrington, Neurology 2010 75 500 507 10.1212/WNL.0b013e3181eccfa2 20610833
18. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, B Landwehrmeyer, C Frost, H Johnson, D Craufurd, R Reilmann, JC Stout, DR Langbehn, Lancet Neurol 2013 12 637 649 10.1016/S1474-4422(13)70088-7 23664844
19. Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. K Duff, JS Paulsen, LJ Beglinger, DR Langbehn, JC Stout, Biol Psychiatry 2007 62 1341 1346 10.1016/j.biopsych.2006.11.034 17481592 (Pubitemid 350180721)
20. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. J Marshall, K White, M Weaver, WL Flury, S Hui, JC Stout, SA Johnson, X Beristain, J Gray, J Wojcieszek, T Foroud, Arch Neurol 2007 64 116 121 10.1001/archneur.64.1.116 17210818 (Pubitemid 46072433)
21. Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996 11 136 142 10.1002/mds.870110204 (Pubitemid 26082779)
22. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. ZS Nasreddine, NA Phillips, V Bedirian, S Charbonneau, V Whitehead, I Collin, JL Cummings, H Chertkow, J Am Geriatr Soc 2005 53 695 699 10.1111/j.1532-5415.2005.53221.x 15817019 (Pubitemid 41623495)
23. LR Derogatis, SCL-90-R Symptom Checklist-90-R Psykologisk forlag, Copenhagen 1977
24. A rating scale for depression. M Hamilton, J Neurol Neurosurg Psychiatry 1960 23 56 62 10.1136/jnnp.23.1.56 14399272
25. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. LR Olsen, EL Mortensen, P Bech, Acta Psychiatr Scand 2004 110 225 229 10.1111/j.1600-0447.2004.00399.x 15283743 (Pubitemid 39120326)
26. Mental distress in the Danish general population. LR Olsen, EL Mortensen, P Bech, Acta Psychiatr Scand 2006 113 477 484 10.1111/j.1600-0447.2005.00743.x 16677224
27. A comparison of depression rating scales. NP Kearns, CA Cruickshank, KJ McGuigan, SA Riley, SP Shaw, RP Snaith, Br J Psychiatry 1982 141 45 49 10.1192/bjp.141.1.45 7116071 (Pubitemid 12074468)
28. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. HE Nelson, A O'Connell, Cortex 1978 14 234 244 10.1016/S0010-9452(78)80049-5 679704 (Pubitemid 8386900)
29. Evaluating storage, retention, and retrieval in disordered memory and learning. H Buschke, PA Fuld, Neurology 1974 24 1019 1025 10.1212/WNL.24.11.1019 4473151
30. JE Meyers, KR Meyers, Rey complex figure test and recognition trial PAR, Lutz, FL 1995
31. The relation of the trail making test to organic brain damage. RM Reitan, J Consult Psychol 1955 19 393 394 10.1037/h0044509 13263471
32. A Smith, Symbol digit modalities test: manual Lutz, FL, PAR 1982
33. Studies of interference in serial verbal reactions. JR Stroop, J Exp Psychol 1935 18 643 662 10.1037/h0054651
34. J Raven, JC Raven, JH Court, Manual for Raven's progressive matrices and vocabulary scales Harcourt Assessment, San Antonio TX 2003
35. On the relation between demographic variables and neuropsychological test performance. EL Mortensen, A Gade, Scand J Psychol 1993 34 305 317 10.1111/j.1467-9450.1993.tb01127.x
36. Do subjective cognitive complaints correlate with cognitive impairment in systemic lupus erythematosus? A Danish outpatient study. A Vogel, S Bhattacharya, JL Larsen, S Jacobsen, Lupus 2011 20 35 43 10.1177/ 0961203310382430 21233148
37. CAG repeat number governs the development rate of pathology in Huntington's disease. JB Penney Jr, JP Vonsattel, ME MacDonald, JF Gusella, RH Myers, Ann Neurol 1997 41 689 692 10.1002/ana.410410521 9153534 (Pubitemid 27212666)
38. A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. JS Paulsen, M Nance, JI Kim, NE Carlozzi, PK Panegyres, C Erwin, A Goh, E McCusker, JK Williams, Prog Neurobiol 2013 110 2 28 10.1016/j.pneurobio.2013.08.003 24036231
39. Cognitive deficits and functional outcomes in major depressive disorders; determinants, substrates and treatment interventions. ehavioural abnormalities contribute to functional decline in Huntington's disease. RS McIntyre, DS Cha, JK Soczynska, H Woldeyohannes, LA Gallaugher, P Kudlow, M Alsuwaidan, A Baskaran, Depress Anxiety 2013 30 515 527 10.1002/da.22063 23468126
40. Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. MM Smith, JA Mills, EA Epping, HJ Westervelt, JS Paulsen, Neuropsychology 2012 26 664 669 10.1037/a0029218 22846033
41. Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression- a systematic review. BT Baune, L Renger, Psych res 2014 219 25 50 10.1016/j.psychres.2014.05.013
42. Behavioural abnormalities contribute to functional decline in Huntington's disease. JM Hamilton, DP Salmon, J Corey-Bloom, A Gamst, JS Paulsen, S Jerkins, MW Jacobson, G Peavy, J Neurol Neurosurg Psychiatry 2003 74 120 122 10.1136/jnnp.74.1.120 12486282 (Pubitemid 36069050)